| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |